- Report
- May 2026
- 182 Pages
Global
From €4055EUR$4,500USD£3,479GBP
- Report
- January 2026
- 196 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- May 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,471GBP
- Report
- September 2026
- 375 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 385 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 377 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 120 Pages
Global
From €7200EUR$7,990USD£6,177GBP
- Report
- May 2026
- 149 Pages
Global
From €3559EUR$3,950USD£3,054GBP
- Report
- October 2025
- 160 Pages
Global
From €2847EUR$3,160USD£2,443GBP
€3559EUR$3,950USD£3,054GBP
- Report
- February 2026
- 197 Pages
Global
From €4370EUR$4,850USD£3,749GBP
- Report
- January 2026
- 150 Pages
Global
From €4370EUR$4,850USD£3,749GBP
- Report
- March 2026
- 208 Pages
United States
From €4370EUR$4,850USD£3,749GBP
- Report
- May 2026
- 300 Pages
Global
From €3600EUR$3,995USD£3,088GBP
- Report
- May 2026
- 800 Pages
Global
From €4501EUR$4,995USD£3,861GBP
- Report
- May 2026
- 450 Pages
Global
From €3600EUR$3,995USD£3,088GBP
- Report
- May 2026
- 700 Pages
Global
From €4501EUR$4,995USD£3,861GBP
- Report
- May 2026
- 500 Pages
Global
From €3600EUR$3,995USD£3,088GBP
- Report
- May 2026
- 241 Pages
Global
From €4324EUR$4,799USD£3,710GBP
- Report
- February 2026
- 202 Pages
Global
From €4324EUR$4,799USD£3,710GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more